Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: A comparison between C6-competent and C6-deficient rabbits

Cardiovascular Research

Volumn 32, Issue 2, 1996, Pages 294-305

  Ito, W ^a,d   Schafer H J ^a   Bhakdi, S ^c   Klask, R ^a   Hansen, S ^a   Schaarschmidt, S ^a   Schofer, J ^a   Hugo, F ^b   Hamdoch, T ^a   Mathey, D ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Arrhythmias; Complement system; Myocardial infarct size; Myocardial infarction; Rabbit, anesthetized; Reperfusion

Indexed keywords

COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIA; COMPLEMENT ACTIVATION; COMPLEMENT C6; COMPLEMENT MEMBRANE ATTACK COMPLEX; ELECTROCARDIOGRAPHY; IMMUNOHISTOCHEMISTRY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RABBITS; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 0030222307     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00082-X     Document Type: Article

References (33)

1. [1] Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 1971;133:885-900.
2. [2] Pinckard RN, Olsen MS, Kelly RE, et al. Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J Immunol 1973;110:1376-1382.
3. [3] Pinckard RN. O'Rourke RA, Crawford MH, et al. Complement localisation and mediation of ischemic injury to baboon myocardium. J Clin Invest 1980;66:1050-1056.
4. [4] McManus LM, Kolb WP, Crawford MH, O'Rourke RA. Grover FL. Pinckard RN. Complement localisation in ischemic baboon my-ocardium. Lab Invest 1983;48:436-447.
5. [5] Rossen RD, Swain JL, Michael LH, Weakley S. Gianninnini E. Entman ML. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischémie injury. Circ Res 1985;57:119-130.
6. [6] Schäfer HJ. Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 1986;137:1945-1949.
7. [7] Crawford MH, Grover FL, Kolb WP, et al. Complement and neutrophil activation in the pathogenesis of ische;mie myocardial injury. Circulation 1988:;78:1449-1458.
8. [8] Mathey D. Schofer J. Schäfer HJ, et al. Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J 1994;15(3):418-423.
9. [9] Smith EF, Griswold DE, Egan JW, et al. Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730) Eur J Pharmacol 1993;236(3):477-481.
10. [10] Shandelya SM, Kuppusamy P, Weisfeld ML, Zweier JL. Evaluation of the role of polymorphonuclear leukocytes of contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation. Circulation 1993;87(2):536-546.
11. [11] Dreyer WJ, Michael LH, Nguyen T, et al. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ Res 1992;71(6):1518-1524.
12. [12] Ross GD. Complement receptor type 1. Curr Top Microbiol Immunol 1992;178:31-44.
13. [13] Müller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988;57:321-347.
14. [14] Bhakdi S, Hugo F, Tranum-Jensen J. Functions and relevance of the terminal complement sequence. Blut 1990;60:309-318.
15. [15] Homeister WH, Satoh P, Lucchesi BR. Effects of complement activation in the isolated heart. Role of the terminal complement components. Circ Res 1992;71:303-319.
16. [16] Lown B, Wolf M. Grading system for ventricular ectopy. Circulation 1971;44:130-142.
17. [17] Forman MB, Bingham S, Kopelman HA, et al. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1985;71:1060-1068.
18. [18] Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validitation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
19. [19] Lie JT. Pairolero PC, Holley KE, et al. Macroscopic enzyme mapping verification of large. homogeneous experimental myocardial infarcts of predictable size and location in dogs. J Thor Cardiovasc Surg 1975;69(4):599-605.
20. [20] Boor PJ, Reynolds ES. A simple planimetric method for determination of left ventricular mass and necrotic myocardial mass in postmortem hearts. Am J Clin Pathol 1977;68:387-392.
21. [21] Schäfer H, Joachim HC, Rodewald W, Schaarschmidt S, Mathey D. Tierexperimentelle Untersuchungen zur frühen Markierung von Myokardinfarkten durch C5b-9 bzw. Propidiumjodid - Einfluß von Ischämie und Reperfusionsdauer. Verh Dtsch Ges Pathol 1992;76:277.
22. [22] Schäfer H, et al. Submitted for publication.
23. [23] Bhakdi S, Greulich S, Muhly M, et al. Potent leukocidal action of Escherichia coli hemolysin mediated by permaeabilization of target cell membranes. J Exp Med 1989;169:737-754.
24. [24] Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974(6);54:1496-1508.
25. [25] Newell S, Gorman JC, Bell E, Atkinson JP. Haemolytic and antigenic measurements of complement. J Lab Clin Med 1982;100:437.
26. [26] Connelly C, Vogel WM, Hernandez YM, Apstein CS. Movement of necrotic wavefront after coronary artery occlusion in rabbit. Am J Physiol 1982;243:H682-H690.
27. [27] Shirato C, Miura T, Ooiwa H, Toyofuku T, Wilborn WH, Downey JM. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. J Mol Cell Cardiol 1989;21:1187-1193.
28. [28] Miura T, Downey JM, Ooiwa H, et al. Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J 1989;30(5):695-708.
29. [29] Darsee JR, Kloner RA. The no-reflow phenomenon: a time-limiting factor for reperfusion after coronary occlusion? Am J Cardiol 1980;61:452-458.
30. [30] Fishbein MC, Y-Rit J, Lando U, Kanmatsuse K, Mercier JC, Ganz W. The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation 1980;62:1274-1279.
31. [31] Manning AS, Hearse DJ. Reperfusion-induced arrhyth mias: mechanisms and prevention. J Mol Cell Cardiol 1984;16:497-518.
32. [32] Wilensky RL, Tranum-Jensen J, Coronel R, Wilde AAM, Piolet JW, Janse MJ. The subendocardial border zone during acute ischemia of the rabbit heart: an electrophysiologic, metabolic, and morphologic correlative study. Circulation 1986;74:1137-1146.
33. [33] Morgan BP. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 1989;264(1):1-14.